__NUXT_JSONP__("/drugs/Roblitinib", (function(a,b,c){return {data:[{drug:{slug:a,emaEpar:[],fdaDrugLabel:[],id:a,nciThesaurus:{casRegistry:"1708971-55-4",chebiId:b,chemicalFormula:b,definition:"An inhibitor of human fibroblast growth factor receptor 4 (FGFR4), with potential antineoplastic activity. Upon administration, roblitinib binds to and inhibits the activity of FGFR4, which leads to an inhibition of tumor cell proliferation in FGFR4-overexpressing cells. FGFR4 is a receptor tyrosine kinase upregulated in certain tumor cells and involved in tumor cell proliferation, differentiation, angiogenesis, and survival.",fdaUniiCode:"M64JF6WMSA",identifier:"C120102",preferredName:a,semanticType:"Pharmacologic Substance",subclassOf:["C155727"],synonyms:["FGF401","FGFR4 Inhibitor FGF401","ROBLITINIB",a]},dir:"\u002Fdrugs",path:"\u002Fdrugs\u002FRoblitinib",extension:".json",createdAt:c,updatedAt:c}}],fetch:{},mutations:void 0}}("Roblitinib","","2021-10-30T13:19:58.093Z")));